Panbela therapeutics investor alert - kuznicki law pllc investigates panbela therapeutics, inc. - pbla

Cedarhurst, n.y.--(business wire)--kuznicki law pllc is investigating the proposed sale of cancer prevention pharmaceuticals, inc. to panbela therapeutics, inc. (“the company”) (nasdaqcm: pbla). under the terms of the proposed transaction, holders of panbela common stock are expected to own only approximately 59% of the post-merger holding company. if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, contact us toll free at 833-
PBLA Ratings Summary
PBLA Quant Ranking